Bms 301 exam 3 - Study guides, Class notes & Summaries

BMS 301 EXAM 3 ALL QUESTIONS AND VERIFIED ANSWERS....

Introduction - Hello, my name is Katie and I am from Glastonbury, CT. I am a freshman here at Quinnipiac. I am a BMS major and I am involved in The Big Event, Relay for Life, and QThon here. I will be giving you your tour today. On tour you will see the academic buildings, student center, library, recreation center and the resident halls. If you have any questions during the tour, just let me know and I will answer them for you. On Route to #1 - - Quinnipiac was founded in 1929 in New Haven...

1. Discrepancy between anatomical sex and gender is known as? 2. Which of the following are risk factors for neuroleptic malignant syndrome? Select all that apply 3. Antipsychotic medication provides D2 blockage in the meso-coritcal pathway causing which of the fol- lowing effects? 4. Phencyclidine (PCP) and ketamine exert their unique behavioral effects by blocking which of the following receptors? 5. The diagnosis used to describe a syndrome charac- terized by speci...

1. Discrepancy between anatomical sex and gender is known as? 2. Which of the following are risk factors for neuroleptic malignant syndrome? Select all that apply 3. Antipsychotic medication provides D2 blockage in the meso-coritcal pathway causing which of the fol- lowing effects? 4. Phencyclidine (PCP) and ketamine exert their unique behavioral effects by blocking which of the following receptors? 5. The diagnosis used to describe a syndrome charac- terized by speci...

1. Discrepancy between anatomical sex and gender is known as? 2. Which of the following are risk factors for neuroleptic malignant syndrome? Select all that apply 3. Antipsychotic medication provides D2 blockage in the meso-coritcal pathway causing which of the fol- lowing effects? 4. Phencyclidine (PCP) and ketamine exert their unique behavioral effects by blocking which of the following receptors? 5. The diagnosis used to describe a syndrome charac- terized by specific s/s resultin...